A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
Guillibert
E
E
Service de Psychiatrie adulte et de Psychologie médicale Hopital Necker, Paris, France.
Pelicier
Y
Y
Archambault
J C
JC
Chabannes
J P
JP
Clerc
G
G
Desvilles
M
M
Guibert
M
M
Pagot
R
R
Poisat
J L
JL
Thobie
Y
Y
D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002997:Clomipramine / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*
D000928:Antidepressive Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D017374:Paroxetine; D002997:Clomipramine